Related Experiment Videos
Cellular effects induced by the antitumor agent azinomycin B
Gilbert T Kelly1, Chaomin Liu, Roger Smith
1Department of Chemistry, Texas A&M University, College Station, Texas 77843, USA.
Chemistry & Biology
|May 25, 2006
Summary
Azinomycin B causes DNA damage in vivo, leading to a robust DNA damage response and cell cycle changes in yeast. This study confirms its role as a covalent DNA modifying agent.
Area of Science:
- Molecular Biology
- Genetics
- Biochemistry
Background:
- Antitumor agent azinomycin B is proposed to work by forming DNA interstrand crosslinks.
- Previous studies focused on in vitro mechanisms of action.
Purpose of the Study:
- To investigate the in vivo biological effects of azinomycin B.
- To confirm its DNA-damaging mechanism in a living organism.
Main Methods:
- Fluorescence imaging to track azinomycin B localization in yeast.
- Oligonucleotide microarrays to analyze transcriptome-wide effects.
- Reverse transcription-polymerase chain reaction (RT-PCR) for gene expression validation.
- Flow cytometry to assess cell cycle progression.
Main Results:
- Azinomycin B localized to the nuclear region of yeast cells.
- Significant DNA damage response observed across the yeast transcriptome.
- RT-PCR confirmed drug-induced gene expression changes.
- Flow cytometry revealed an S phase shift, indicating transcriptional effects.
Conclusions:
- Azinomycin B elicits biological effects in vivo, consistent with its proposed mechanism.
- The drug acts as a covalent DNA modifying agent, inducing a DNA damage response.
- Transcriptional effects and cell cycle alterations are key consequences of azinomycin B treatment in vivo.